|
此文章由 胡桃jia子 原创或转贴,不代表本站立场和观点,版权归 oursteps.com.au 和作者 胡桃jia子 所有!转贴必须注明作者、出处和本声明,并保持内容完整
再更新吧,可能妈妈们都知道了,不过我想强调其中三条,
1,该问题是在例行巡检时候发现问题的,并不是检查出药品真的有问题。2,加拿大卫生部发言人说到现在为止还没有发现有污染的产品。3,同一栋楼里怀疑有污染的用于治疗膀胱癌的BCG疫苗并没有被回收,还在继续使用,原因是收益大于风险。
既然这样,也许真的没那么糟?不知道官方说法可信不。
The concerns came to light following routine inspections of the company's Toronto manufacturing facility in May and early June, a senior Health Canada official said in an interview.
Dr. Paul Gully said the building in which the vaccine is made was flooded last October, and there remain ongoing production challenges related to the flood.
"It made Health Canada concerned there is a possibility of contamination," said Gully, senior medical adviser to the deputy minister of Health Canada. Gully said, though, that testing so far has not identified any contaminated product.
Three adverse reactions potentially linked to the recalled vaccine lots have been reported. All were the kind of mild reactions normally associated with this vaccine, Health Canada said.
There was no one at Sanofi's Canadian operations who could comment on the recall on Friday.
While Sanofi Pasteur makes other vaccines at its Toronto plant, only BCG vaccine is made in the affected building. BCG stands for Bacille Calmette-Guerin, named after Albert Calmette and Camille Guerin who developed the live-bacteria vaccine in the early 1900s.
BCG is also used as a treatment for bladder cancer. The bladder cancer product is made in the same building as the vaccine, but those lots are not being recalled. Gully explained the risk-benefit ratio is different when one is trying to prevent serious disease (in the case of the vaccine) versus when one is trying to treat it (the bladder cancer). |
评分
-
查看全部评分
|